Search

Your search keyword '"Sarcoma, Kaposi physiopathology"' showing total 204 results

Search Constraints

Start Over You searched for: Descriptor "Sarcoma, Kaposi physiopathology" Remove constraint Descriptor: "Sarcoma, Kaposi physiopathology" Topic sarcoma, kaposi Remove constraint Topic: sarcoma, kaposi
204 results on '"Sarcoma, Kaposi physiopathology"'

Search Results

2. Pseudomonas aeruginosa Stimulates Inflammation and Enhances Kaposi's Sarcoma Herpesvirus-Induced Cell Proliferation and Cellular Transformation through both Lipopolysaccharide and Flagellin.

Catalog

Books, media, physical & digital resources

3. Sperm associated antigen 9 promotes oncogenic KSHV-encoded interferon regulatory factor-induced cellular transformation and angiogenesis by activating the JNK/VEGFA pathway.

4. Kaposi Sarcoma-Associated Herpesvirus Infection and Endemic Burkitt Lymphoma.

5. Rare presentation of bronchopulmonary Kaposi sarcoma.

6. [How do we treat Kaposiform Haemangioendothelioma?]

7. Plantar Kaposi Sarcoma Revealed by Antisynthetase Syndrome.

8. Recommendations for Counseling and Education of Service Members on Endemic African Cutaneous Kaposi Sarcoma: A Case Study.

9. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.

10. Plasma Cell Variant Multicentric Castleman Disease and Kaposi's Sarcoma in a Treatment-Naive HIV-Infected Patient.

11. Signal Transduction Pathways Associated with KSHV-Related Tumors.

12. [Kaposi's Sarcoma in patients with late HIV diagnosis. Case report and review of literature.]

13. IKKγ-Mimetic Peptides Block the Resistance to Apoptosis Associated with Kaposi's Sarcoma-Associated Herpesvirus Infection.

14. Kaposi's sarcoma herpesvirus-induced endothelial cell reprogramming supports viral persistence and contributes to Kaposi's sarcoma tumorigenesis.

15. Restricted Range of Motion and a Cold Upper Extremity in a Two-Year-Old Boy: Kaposiform Hemangioendothelioma of the Bone and the Brachial Plexus: A Case Report.

16. Updating vital status by tracking in the community among patients with epidemic Kaposi sarcoma who are lost to follow-up in sub-Saharan Africa.

17. KSHV microRNAs: Tricks of the Devil.

18. Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNAs promote matrix metalloproteinases (MMPs) expression and pro-angiogenic cytokine secretion in endothelial cells.

19. KSHV non-structural membrane proteins involved in the activation of intracellular signaling pathways and the pathogenesis of Kaposi's sarcoma.

20. HIV/AIDS-associated Kaposi's sarcoma of the gastrointestinal tract: A pictorial spectrum.

21. Activation of cellular metabolism during latent Kaposi's Sarcoma herpesvirus infection.

22. A Woman in Her 30s With a Past History of HIV Disease Presented With Recurrent Fever, Night Sweats, and Small Bilateral Pulmonary Nodules.

23. [Kasabach-Merritt phenomenon (KMP) exacerbated by platelet transfusions].

24. Cellular MicroRNA Let-7a Suppresses KSHV Replication through Targeting MAP4K4 Signaling Pathways.

25. Time to initiation of antiretroviral therapy in HIV-infected patients diagnosed with an opportunistic disease: a cohort study.

26. Fulminant HHV-8 associated Castleman's disease in a non-HIV, Kaposi sarcoma patient with borderline hemophagocytic syndrome.

27. [Fatal HHV-8-associated hemophagocytic syndrome in an HIV-negative patient].

28. Clinical case of the month: a 22-year-old man with AIDS presenting with shortness of breath and an oral lesion.

29. Inhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jκ.

30. Humanized-BLT mouse model of Kaposi's sarcoma-associated herpesvirus infection.

31. Evaluation of non-invasive multispectral imaging as a tool for measuring the effect of systemic therapy in Kaposi sarcoma.

32. Peginterferon alfa-2a for AIDS-associated Kaposi sarcoma: experience with 10 patients.

33. Giant vascular malformation with thrombocytopenia in a newborn.

34. Systemically circulating viral and tumor-derived microRNAs in KSHV-associated malignancies.

35. The KSHV viral IL-6 homolog is sufficient to induce blood to lymphatic endothelial cell differentiation.

36. KSHV-initiated notch activation leads to membrane-type-1 matrix metalloproteinase-dependent lymphatic endothelial-to-mesenchymal transition.

37. Kaposi's sarcoma: imaging overview.

38. Pathomorphosis of the classical Caposi's sarcoma: anamnesis, catamnesis, clinics.

39. New drug targets in Kaposi sarcoma.

40. Regression of conjunctival tumor during dietary treatment of celiac disease.

41. Viral G protein-coupled receptor up-regulates Angiopoietin-like 4 promoting angiogenesis and vascular permeability in Kaposi's sarcoma.

42. KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming.

43. Kaposi sarcoma related to an ectopic hypothalamic adrenocorticotropic hormone-secreting adenoma: case report.

44. Patellofemoral knee pain in an adult with radiographic osteoarthritis and human immunodeficiency virus infection.

45. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation.

46. Presentation and survival of patients with AIDS-related Kaposi's sarcoma in Jos, Nigeria.

47. The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade.

48. HIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease.

49. [Classic dissemination of Kaposi's sarcoma: report of a case].

50. Progression of Kaposi sarcoma associated with iatrogenic Cushing syndrome in a person with HIV/AIDS.